Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-079-9 | CAS number: 68515-38-8 A complex combination of hydrocarbons produced by the esterification of phthalic anhydride with isodecyl alcohol. It consists predominantly of C10 primary aliphatic alcohols, C9-10 paraffins, saturated and unsaturated C20 ethers and boiling in the range of approximately 120°C to 230°C (248°F to 446°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 26 March 2019 to 16 April 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- yes
- Remarks:
- The age of the animals was 6 to 8 weeks (beginning of treatment).The deviation does affect the validity of the study.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
Test material
- Reference substance name:
- 1,2-Benzenedicarboxylic acid, isodecyl ester, manuf. of, by-products from
- EC Number:
- 271-079-9
- EC Name:
- 1,2-Benzenedicarboxylic acid, isodecyl ester, manuf. of, by-products from
- Cas Number:
- 68515-38-8
- Molecular formula:
- n/a
- IUPAC Name:
- 1,2-Benzenedicarboxylic acid, isodecyl ester, manuf. of, by-products from
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V., Inc
- Age at study initiation: 7-8 weeks of age
- Weight at study initiation: females (160.1-172.1 g)
- Fasting period before study: Overnight
- Housing: 1-5 per cage (same sex and dose group)
- Diet (e.g. ad libitum): 2018C Teklad Global 18% protein rodent diet, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 45-65
- Artificial light: 6.00 a.m.-6.00 p.m.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Remarks:
- The test item was formulated at a concentration of 200 mg/mL in the vehicle and administered at a constant dose volume of 10 mL/kg body weight (2000 mg/kg body weight).
- Details on oral exposure:
- Dose administration was once orally by gavage (feeding needle). The volume administered did not exceed 10 mL/kg b.w.
Based on available information on the toxicity of the test item, 2000 mg/kg was chosen as the initial starting dose, since a severe toxicity which may necessitate humane euthanasia was not expected at this dose level. - Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 (2000 mg/kg); all animals tested were female.
- Control animals:
- no
- Details on study design:
- - Duration of clinical observation period following administration: 0.5, 1, 2, and 4 hours after dosing and daily thereafter for 14 days.
- Mortality and morbidity checks were made 3 times in the first 6 hours and then at least once daily
- Frequency of observations and weighing: Day 0 (prior to dosing), Day 7, and Day 14
- Necropsy of survivors performed: yes
- Animals were killed by carbon dioxide asphyxiation followed by cervical dislocation
- Other examinations performed: clinical signs, changes in the skin and fur, eyes and mucous membranes, and respiratory, circulatory, autonomic and central nervous system, and somatomotor activity and behavior pattern. Particular attention was directed to the observation of tremors, convulsions, salivation, diarrhea, lethargy, sleep and coma.
Results and discussion
- Preliminary study:
- A sighting study using one rat at the 2000 mg/kg dose level. In the absence of mortality or toxicity at a dose level of 2000 mg/kg, an additional group of 4 rats were dosed at 2000 mg/kg (n=5 total rats at 2000 mg/kg). There were no deaths during the study.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no deaths observed
- Mortality:
- No deaths observed.
- Clinical signs:
- Clinical signs observed were hunched posture and piloerection seen in all females dosed at the 2000 mg/kg dose level 30 minutes after dosing. Aniamls 2 to 5 additionally showed decrease activity 30 minutes after dosing. Additionally, partially closed eyes, lethargy, tiptoe gait, tremor of the head and noisy respiration was observed in animal 1 on the day of application. On day 2 this animal additionally showed ataxia and sunken flanks. Recovery of the animals, as judged by external appearance and behavior, was complete by Day 2 of animals 2-4 and on day 3 of animal 1.
- Body weight:
- All animals showed expected gains in body weight over the observation period.
- Gross pathology:
- Animal 1 and 2 showed enlarged genitals filled with clear liquid. In animal 3 a plethora of the thymus was observed while in animal 4 a plethora of the rectum bood vessels could be seen while the intestine of animal 4 was empty. No abnormalities were noted at necropsy in animal 5.
- Other findings:
- No other signs of toxicity.
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The acute oral median lethal dose (LD50) of the study substance in the female Wistar strain rat was estimated to be greater than 2000 mg/kg body weight (Globally Harmonized Classification System − Category 5).
- Executive summary:
Acute oral toxicity of the study substance was assessed in the female Wistar strain rat.
Following a sighting test at a dose level of 2000 mg/kg b.w. in one female rat, a further group of four fasted females was given a single oral dose of study substance, as a solution in corn oil, at a dose level of 2000 mg/kg body weight. Clinical signs and body weight development were monitored in all animals during the study. All animals were subjected to gross necropsy.
No deaths were observed. Clinical signs observed were hunched posture and piloerection seen in all females dosed at 2000 mg/kg. These signs were first noted approximately 30 minutes after dosing. Aniamls 2 to 5 additionally showed decrease activity 30 minutes after dosing. Additionally, partially closed eyes, lethargy, tiptoe gait, tremor of the head and noisy respiration was observed in animal 1 on the day of application. On day 1 animal 2 additionally showed ataxia and sunken flanks. Recovery of the animals, as judged by external appearance and behavior, was complete by Day 1 of animals 1 and 3-5 and on day 3 of animal 2. All animals showed expected gains in body weight. Animal 1 and 2 showed enlarged genitals filled with clear liquid. In animal 3 a plethora of the thymus was observed while in animal 4 a plethora of the rectum bood vessels was observed while the intestine of animal 4 was empty. No abnormalities were noted at necropsy in animal 5.
From these results it can be concluded that the acute oral median lethal dose (LD50) of the study substance in the female Wistar strain rat was estimated to be greater than 2000 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
